Form D · Venture Capital Fund

Remiges BioPharma Fund II, LP

Cambridge, MA · CIK 0001779994

Offering snapshot reported Jun 20, 2019 · SEC filing

Reported sold: Yet to sell
Investors reported: 0
Minimum accepted: $0
First sale: Yet to occur

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 20, 2019	Amendment	Yet to sell	No comparison	0	SEC filing
Jun 19, 2019	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-342260

Source: Form D, filed Jun 20, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

REMIGES BIOPHARMA FUND II, LP

Investment adviser: REMIGES VENTURES, INC.

Gross asset value: $95M
Beneficial owners: 6
ADV minimum commitment: $0

Reported in Form ADV on Jan 9, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALTER DOMUS NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor GRANT THORNTON NEW YORK, New York, United States

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: No
Administrator other than the adviser: Yes
External marketing: No

GRANT THORNTON
PCAOB 248

Filing source

Form ADV 2033599 · Jan 9, 2026 · Schedule D 7.B.(1), fund 805-3153069367

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
Remiges BioPharma Fund, LP	Mar 9, 2017	$80,000,000	4
Remiges BioPharma Fund II, LP (this fund)	Jun 20, 2019	Yet to sell	0

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Taro Inaba	Director
Walter Olesiak	Director
N/A Remiges Bio Pharma Fund Gp Ii, Inc.	Director, Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

One Broadway, 14 Th Floor
Cambridge, MA, 02142